Mauritius vs South-Eastern Asia: Proportion of the target population who received a 3rd dose of
Mauritius
95.0%
in 2024
South-Eastern Asia
56.0%
in 2024
Mauritius rank
28th
South-Eastern Asia rank
28th
Proportion of the target population who received a 3rd dose of over time
- Mauritius
- South-Eastern Asia
How they compare
Mauritius currently reports 95.0% against 56.0% in South-Eastern Asia, a difference of 39.0%.
That makes Mauritius's figure about 1.7 times South-Eastern Asia's.
The two have swapped places 1 time across 9 shared years of data; in 2016 it was South-Eastern Asia ahead.
Mauritius ranks 28th and South-Eastern Asia ranks 28th of 157 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.8% | 19.8% | 52.0% | Mauritius |
| 2020s | 94.4% | 35.6% | 58.8% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Mauritius or South-Eastern Asia?
- Mauritius, at 95.0% against 56.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Mauritius and South-Eastern Asia?
- 39.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and South-Eastern Asia?
- 9 years are reported by both, from 2016 to 2024.
- How do Mauritius and South-Eastern Asia rank globally for proportion of the target population who received a 3rd dose of?
- Mauritius ranks 28th and South-Eastern Asia ranks 28th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.